Multivariable prognostic analysis for DFS and risk of BM relapse (on 93 patients evaluable for all risk variables)
Risk factor . | No. (%) . | DFS . | BM relapse . | ||||||
---|---|---|---|---|---|---|---|---|---|
Hazard ratio . | SE . | 95% CI . | P . | Hazard ratio . | SE . | 95% CI . | P . | ||
MRDpos | 44 (47.3) | 5.88 | 2.16 | 2.86-12.08 | .001 | 5.33 | 2.20 | 2.38-11.96 | .001 |
WBC more than 100 | 9 (9.7) | 5.13 | 2.38 | 2.06-12.75 | .001 | 4.32 | 2.25 | 1.56-11.99 | .005 |
WBC more than 30 | 24 (25.8) | 2.57 | 0.88 | 1.32-5.02 | .006 | 2.27 | 0.90 | 1.04-4.96 | .040 |
HR phenotype | 16 (17.2) | 1.68 | 0.64 | 0.79-3.55 | .176 | 2.04 | 0.85 | 0.90-4.63 | .085 |
HR cytogenetics | 23 (24.7) | 1.04 | 0.38 | 0.52-2.12 | .901 | 0.96 | 0.41 | 0.42-2.21 | .934 |
Age older than 55 y | 15 (16.1) | 1.36 | 0.67 | 0.52-3.59 | .530 | 1.44 | 0.80 | 0.49-4.29 | .508 |
Risk factor . | No. (%) . | DFS . | BM relapse . | ||||||
---|---|---|---|---|---|---|---|---|---|
Hazard ratio . | SE . | 95% CI . | P . | Hazard ratio . | SE . | 95% CI . | P . | ||
MRDpos | 44 (47.3) | 5.88 | 2.16 | 2.86-12.08 | .001 | 5.33 | 2.20 | 2.38-11.96 | .001 |
WBC more than 100 | 9 (9.7) | 5.13 | 2.38 | 2.06-12.75 | .001 | 4.32 | 2.25 | 1.56-11.99 | .005 |
WBC more than 30 | 24 (25.8) | 2.57 | 0.88 | 1.32-5.02 | .006 | 2.27 | 0.90 | 1.04-4.96 | .040 |
HR phenotype | 16 (17.2) | 1.68 | 0.64 | 0.79-3.55 | .176 | 2.04 | 0.85 | 0.90-4.63 | .085 |
HR cytogenetics | 23 (24.7) | 1.04 | 0.38 | 0.52-2.12 | .901 | 0.96 | 0.41 | 0.42-2.21 | .934 |
Age older than 55 y | 15 (16.1) | 1.36 | 0.67 | 0.52-3.59 | .530 | 1.44 | 0.80 | 0.49-4.29 | .508 |
WBC indicates white blood cell (×109/L).